BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ojeda JM, Ampuero S, Rojas P, Prado R, Allende JE, Barton SA, Chakraborty R, Rothhammer F. p53 codon 72 polymorphism and risk of cervical cancer. Biol Res. 2003;36:279-283. [PMID: 14513722 DOI: 10.4067/s0716-97602003000200017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Isakova J, Vinnikov D, Bukuev N, Talaibekova E, Aldasheva N. ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women. Asian Pac J Cancer Prev 2019;20:1057-62. [PMID: 31030474 DOI: 10.31557/APJCP.2019.20.4.1057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Mao JJ, Wu LX, Wang W, Ye YY, Yang J, Chen H, Yang QF, Zhang XY, Wang B, Chen WX. Nucleotide variation in ATG4A and susceptibility to cervical cancer in Southwestern Chinese women. Oncol Lett 2018;15:2992-3000. [PMID: 29435029 DOI: 10.3892/ol.2017.7663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
3 Ostrow SL, Hershberg R. The Somatic Nature of Cancer Allows It to Affect Highly Constrained Genes. Genome Biol Evol 2016;8:1614-20. [PMID: 27190005 DOI: 10.1093/gbe/evw110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA, Khussainova EM. The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 2013;4:70. [PMID: 23675381 DOI: 10.3389/fgene.2013.00070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
5 Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011;17:132-44. [PMID: 22345983 DOI: 10.4103/0971-6866.92087] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
6 Robles AI, Harris CC. Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol. 2010;2:a001016. [PMID: 20300207 DOI: 10.1101/cshperspect.a001016] [Cited by in Crossref: 155] [Cited by in F6Publishing: 182] [Article Influence: 12.9] [Reference Citation Analysis]
7 Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:755-761. [PMID: 20200430 DOI: 10.1158/1055-9965.epi-09-0886] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
8 Ueda M, Toji E, Nunobiki O, Izuma S, Okamoto Y, Torii K, Noda S. Germline polymorphism of cancer susceptibility genes in gynecologic cancer. Hum Cell 2008;21:95-104. [PMID: 19067761 DOI: 10.1111/j.1749-0774.2008.00058.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
9 Malmer BS, Feychting M, Lönn S, Lindström S, Grönberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C, Kiuru A, Mudie N, Salminen T, Schoemaker MJ, Swerdlow AJ, Henriksson R. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 2007;82:229-37. [PMID: 17151932 DOI: 10.1007/s11060-006-9275-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
10 Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
11 Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol 2005;58:26-31. [PMID: 15623478 DOI: 10.1136/jcp.2004.019315] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
12 Lu XM, Zhang YM, Lin RY, Liang XH, Zhang YL, Wang X, Zhang Y, Wang Y, Wen H. p53 polymorphism in human papillomavirus-associated Kazakh’s esophageal cancer in Xinjiang, China. World J Gastroenterol 2004; 10(19): 2775-2778 [PMID: 15334668 DOI: 10.3748/wjg.v10.i19.2775] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]